Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. (Q54572718)

1 June 2018

title

Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients. (English)

1 reference

1 June 2018

main subject

multiple sclerosis

0 references

author

Bianca Weinstock-Guttman

1

Bianca Weinstock-Guttman

1 reference

1 June 2018

4

Miriam Tamaño-Blanco

1 reference

1 June 2018

11

Murali Ramanathan

1 reference

1 June 2018

5

Darlene Badgett

1 reference

1 June 2018

Joan Feichter

8

Joan Feichter

1 reference

1 June 2018

Patrick J Karas

6

Kara Patrick

1 reference

1 June 2018

Roseane Maria Maia Santos

3

Roseane Santos

1 reference

1 June 2018

Monika L Bayer

7

Monika Baier

1 reference

1 June 2018

Neeta Garg

10

Neeta Garg

1 reference

1 June 2018

author name string

Jianming Hong

2

1 reference

1 June 2018

Eileen Gallagher

9

1 reference

1 June 2018

publication date

1 October 2006

1 reference

1 June 2018

Multiple Sclerosis Journal

published in

1 reference

1 June 2018

volume

12

1 reference

1 June 2018

issue

5

1 reference

1 June 2018

page(s)

541-550

1 reference

1 June 2018

Risk of bone loss in men with multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Fracture history and bone loss in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

RANK-L and RANK: T cells, bone loss, and mammalian evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Genomic organization and transcriptional regulation of human Apo2/TRAIL gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Signaling crosstalk between RANKL and interferons in osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

PTH differentially regulates expression of RANKL and OPG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Estrogen receptor alpha, but not estrogen receptor beta, is involved in the regulation of the OPG/RANKL (osteoprotegerin/receptor activator of NF-kappa B ligand) ratio and serum interleukin-6 in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Regulatory mechanisms of osteoblast and osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

New insight in the mechanism of osteoclast activation and formation in multiple myeloma: focus on the receptor activator of NF-kappaB ligand (RANKL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Genomic effects of IFN-beta in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Reduced pulmonary function in patients with spinal osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458506070605

21 January 2018

Identifiers

DOI

10.1177/1352458506070605

1 reference

1 June 2018

PubMed ID

17086898

1 reference

1 June 2018